NCT00864448View on ClinicalTrials.gov

A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

October 31, 2004

Study Completion Date

October 31, 2004

Conditions
Healthy
Interventions
DRUG

Ramipril10 mg Capsules, single dose

A: Experimental Subjects received Purepac formulated products under fasting conditions

DRUG

Atlace® 10 mg capsules, single dose

B: Active comparator Subjects received Monarch Pharmaceuticals Inc. formulated products under fasting conditions

Trial Locations (1)

78759

CEDRA Clinical Research, LLC, Austin

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY

NCT00864448 - A Relative Bioavailability Study of Ramipril 10 mg Capsules Under Fasting Conditions | Biotech Hunter | Biotech Hunter